BHA specialise in commercial strategic business development and licensing in the
healthcare and related industries. Working with pharmaceutical, drug and device development
companies worldwide, BHA have delivered strategic insight, product positioning and
new business to a growing client base.
Founded in 2006 by Paul Ballington, the consultancy’s primary focus has been in drug
delivery technologies and device development in fields as diverse as respiratory
medicine and general surgery. Most recently BHA has assisted clients in the Japanese
market where experience, contacts and a knowledge of this market’s dynamics are essential
Paul Ballington’s background is in sales and marketing for large pharmaceutical and
medical devices companies such as Schering AG and Baxter, before working in business
development at Abbott. Prior to founding BHA he was a UK plc board director where
he gained significant recognition as a deal maker with expertise in the global drug
BHA have the ability and contacts to help guide your product’s development, your
R&D and commercial strategies and to help find partners and licensees for your product.